Learn / SLDB
NASDAQ: SLDB
Solid Biosciences (SLDB) stock, explained like you're 5
Solid Biosciences trades on the Nasdaq under the ticker SLDB. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 737 million dollars.
- Ticker
- SLDB
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Small cap, about 737 million dollars
Is Solid Biosciences a small, medium or large cap company?
No. Solid Biosciences is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 737 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Solid Biosciences makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves SLDB stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Where Will Solid Biosciences Inc (SLDB) Stock Be in the Next 12 Months? (Yahoo Finance)
- SLDB Initiated Coverage by UBS Rating Set to Buy with $20 Pri (GuruFocus)
- Solid Biosciences: A Funded Challenge To Duchenne Gene Therapy’s Limitations (NASDAQ:SLDB) (Seeking Alpha)
- A new hire's 8,150 stock awards vest in four equal annual installments, if they stay. (Stock Titan)
- SLDB Forecast Price Target Prediction for 2027 (TradingView)
Follow SLDB in your daily brief
Each trading day at 5 PM ET we post what happened to Solid Biosciences and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow SLDB
Questions about Solid Biosciences stock
What does Solid Biosciences do?
Solid Biosciences trades on the Nasdaq under the ticker SLDB. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 737 million dollars.
What is the ticker symbol for Solid Biosciences?
Solid Biosciences trades under the ticker SLDB on the Nasdaq.
What is Solid Biosciences's market cap?
Solid Biosciences is a small cap stock with a market cap of about 737 million dollars.
How does Solid Biosciences make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves SLDB stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow SLDB stock every day?
Add SLDB to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.